We delve into the world of psychedelic medicine with Hadas Alterman, Director of Government Affairs at APPA, where we explore their mission to revolutionize healthcare, the groundbreaking professional practice guidelines for psychedelic therapy, and their strategic partnership with The Daschle Group, all aimed at advancing the integration of psychedelics into mainstream healthcare.
Insights Into the First Psychedelic-Assisted Therapy Guidelines With Hadas Alterman
Similar Posts
Suing the City of Oakland for Mushroom Raid with Dave Hodges
In this episode, Dave speaks to Dennis Walker about how Oakland PD raided his church and confiscated $200,000 worth of sacraments.
Ketamine Therapy for High Performance Athletes with Dr. Sam Zand and Derek Du Chesne
In this episode, we discuss how ketamine therapy can help high-performance professional athletes and corporate executives.
How To Prepare For Your First Psychedelic Trip in 5 EASY Steps
How to Prepare for your First Psychedelic Trip in 5…
Interview With Dr. Joseph Tucker
MagicMed Industries’ CEO, Dr. Joseph Tucker, talks about their psychedelic library, the company’s plans to go public and what the future of psychedelic research looks like.
Interview With Pierre Bouchard
Psychotherapist, Pierre Bouchard talks with our Director of Content, Jill Ettinger.
Interview with James Lanthier, CEO of Mindset Pharma
CEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the 4 new psychedelics they are creating. He also discusses some big breaking news!